Kayama H, Takeda K
Inflamm Regen. 2024; 44(1):42.
PMID: 39327633
PMC: 11426228.
DOI: 10.1186/s41232-024-00355-0.
Digby-Bell J, Atreya R, Monteleone G, Powell N
Nat Rev Gastroenterol Hepatol. 2019; 17(1):9-20.
PMID: 31767987
DOI: 10.1038/s41575-019-0228-5.
Mehta A, Gracias D, Croft M
Cytokine. 2016; 101:14-18.
PMID: 27531077
PMC: 5305780.
DOI: 10.1016/j.cyto.2016.08.003.
Nakayama M, Sugiyama Y, Yamasawa H, Soda M, Mato N, Hosono T
Inflammation. 2012; 35(4):1294-301.
PMID: 22367599
PMC: 3397232.
DOI: 10.1007/s10753-012-9441-x.
Su D, Wang J, Lin Q, Cooper M, Watanabe T
Immunology. 1997; 90(4):543-9.
PMID: 9176107
PMC: 1456697.
DOI: 10.1046/j.1365-2567.1997.00205.x.
Mechanisms of cytokine-mediated localized immunoprotection.
Sarvetnick N
J Exp Med. 1996; 184(5):1597-600.
PMID: 8920849
PMC: 2192879.
DOI: 10.1084/jem.184.5.1597.
In vivo expression of interleukin-1 beta (IL-1 beta), IL-2, IL-4, IL-6, tumour necrosis factor-alpha and interferon-gamma in the fetal murine thymus.
Deman J, van Meurs M, Claassen E, Humblet C, Boniver J, DeFresne M
Immunology. 1996; 89(1):152-7.
PMID: 8911153
PMC: 1456668.
Reduced production of immunoreactive interleukin-1 by peripheral blood monocytes of patients with acute and chronic viral hepatitis.
Muller C, Knoflach P, Zielinski C
Dig Dis Sci. 1993; 38(3):477-81.
PMID: 8444079
DOI: 10.1007/BF01316502.
Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri.
Zychlinsky A, Fitting C, Cavaillon J, Sansonetti P
J Clin Invest. 1994; 94(3):1328-32.
PMID: 8083373
PMC: 295219.
DOI: 10.1172/JCI117452.
Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.
Yang X, Tisch R, Singer S, Cao Z, Liblau R, Schreiber R
J Exp Med. 1994; 180(3):995-1004.
PMID: 8064245
PMC: 2191653.
DOI: 10.1084/jem.180.3.995.
Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.
Locksley R, Crowe S, Sadick M, Heinzel F, GARDNER Jr K, McGrath M
J Clin Invest. 1988; 82(6):2097-105.
PMID: 3264291
PMC: 442793.
DOI: 10.1172/JCI113831.
Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6.
Le J, Fredrickson G, Reis L, DIAMANTSTEIN T, Hirano T, Kishimoto T
Proc Natl Acad Sci U S A. 1988; 85(22):8643-7.
PMID: 3263651
PMC: 282515.
DOI: 10.1073/pnas.85.22.8643.
Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice.
Satoh J, Seino H, Abo T, Tanaka S, Shintani S, Ohta S
J Clin Invest. 1989; 84(4):1345-8.
PMID: 2794065
PMC: 329797.
DOI: 10.1172/JCI114304.
Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.
Merrill J, Koyanagi Y, Chen I
J Virol. 1989; 63(10):4404-8.
PMID: 2789293
PMC: 251058.
DOI: 10.1128/JVI.63.10.4404-4408.1989.
In vivo antitumor mechanism of natural human tumor necrosis factor involving a T cell-mediated immunological route.
Asami T, Imai M, Tanaka Y, Hosaka Y, Kato K, Nakamura N
Jpn J Cancer Res. 1989; 80(12):1161-4.
PMID: 2516844
PMC: 5917930.
DOI: 10.1111/j.1349-7006.1989.tb01648.x.
Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation.
Koch F, Heufler C, Kampgen E, Schneeweiss D, Bock G, Schuler G
J Exp Med. 1990; 171(1):159-71.
PMID: 2404080
PMC: 2187649.
DOI: 10.1084/jem.171.1.159.
Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation.
Ramilo O, Saez-Llorens X, Mertsola J, Jafari H, Olsen K, Hansen E
J Exp Med. 1990; 172(2):497-507.
PMID: 2373990
PMC: 2188350.
DOI: 10.1084/jem.172.2.497.
Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release.
McKenna T
J Clin Invest. 1990; 86(1):160-8.
PMID: 2365814
PMC: 296703.
DOI: 10.1172/JCI114679.
Tumor necrosis factor: an update on basic research and clinical applications.
Schleuning M, Munker R
Klin Wochenschr. 1990; 68(17):841-6.
PMID: 2214607
DOI: 10.1007/BF01662779.
Expression of early activation antigen (CD69) during human thymic development.
Jung L, Haynes B, Nakamura S, Pahwa S, Fu S
Clin Exp Immunol. 1990; 81(3):466-74.
PMID: 2204504
PMC: 1534971.
DOI: 10.1111/j.1365-2249.1990.tb05357.x.